Trial Profile
A Phase III, Randomized, Comparative, Open-label Study of Intravenous Iron Oligosaccharide (Monofer) Administered by Infusions or Repeated Bolus Injections in Comparison With Oral Iron Sulphate in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Ferric derisomaltose (Primary) ; Ferrous sulfate
- Indications Iron deficiency anaemia
- Focus Registrational; Therapeutic Use
- Acronyms PROCEED
- Sponsors Pharmacosmos
- 12 Jun 2014 New trial record